NETRIS PHARMA

Overcome cancer resistance

Lyon, France · Founded 2008 · $8.7M raised

Headquarters
Lyon
Employees
11–50
Founded
2008
Business Model
B2B
Total Funding
$8.7M
Last Round
$8.7M Extension RoundDec 2023
Rounds
1

About

NETRIS Pharma is a clinical-stage biopharmaceutical company based in Lyon, France, developing first-in-class therapeutics that target Netrin-1 to overcome cancer resistance to chemotherapy, targeted therapy, and immunotherapy. Officially created in 2008 as the first spin-off of Centre Leon Berard and the Cancer Research Center of Lyon (CRCL), the company holds a worldwide-exclusive patent portfolio on dependence-receptor biology and partners with leading clinical, research, and corporate organizations to advance its pipeline.

Summary

NETRIS PHARMA is a Biotech company based in Lyon, France, founded in 2008. It has raised $8.7M in total across 1 round, most recently a $8.7M Extension Round round in Dec 2023. Investors include EIC Fund.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundSeries A ExtensionDec 2023
$8.7M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NETRIS PHARMA on Indexed.vc
<a href="https://indexed.vc/companies/netris-pharma"><img src="https://indexed.vc/api/badge/company/netris-pharma" alt="NETRIS PHARMA on Indexed.vc" width="260" height="76" /></a>